Literature DB >> 15536641

Regulation of lung cancer cell growth and invasiveness by beta-TRCP.

Nonggao He1, Chengxin Li, Xiaoli Zhang, Tao Sheng, Sumin Chi, Kai Chen, Qian Wang, Roger Vertrees, Roberto Logrono, Jingwu Xie.   

Abstract

Beta-transducin-repeat-containing protein (beta-TRCP) serves as a substrate-recognition subunit of Skp1/Cullin/F-box (SCF)(beta-TRCP) E3 ligases, involved in regulation of several important signaling molecules. SCF(beta-TRCP) E3 ligases play a critical role in cell mitosis as well as in various signaling pathways. Here, we provide evidence to support that beta-TRCP negatively regulates cell growth and motility of lung cancer cells. With specific antibodies, we detect loss of beta-TRCP1 protein in several lung cancer cell lines. One cell line contains an inactivated mutation of the beta-TRCP1 gene. Loss of beta-TRCP1 protein is also found in subsets of lung cancer specimens. We observe that retrovirus-mediated stable expression of beta-TRCP1 in beta-TRCP1 negative cells inhibits cell growth in soft-agar and tumor formation in nude mice. Furthermore, expression of beta-TRCP1 alters cell motility, as indicated by morphological changes and a reduced level of active matrix metalloproteinase (MMP)11. Conversely, inactivation of beta-TRCP1 by specific siRNA accelerates cell invasion. Of the 10 known substrates of SCF(beta-TRCP) E3 ligases, the protein level of cell division cycle 25 (CDC25)A is clearly affected in these lung cancer cells. Cells treated with CDC25A inhibitors become less invasive. Thus, loss of beta-TRCP1 may promote both growth and cell motility of lung cancer cells, possibly through regulation of CDC25A and the MMP11 level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15536641     DOI: 10.1002/mc.20063

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  14 in total

1.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

Review 3.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

4.  β-transducin repeat-containing E3 ubiquitin protein ligase inhibits migration, invasion and proliferation of glioma cells.

Authors:  Jun Liang; Wei-Feng Wang; Shao Xie; Xian-Li Zhang; Wei-Feng Qi; Xiu-Ping Zhou; Jin-Xia Hu; Qiong Shi; Ru-Tong Yu
Journal:  Oncol Lett       Date:  2017-07-07       Impact factor: 2.967

5.  Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis.

Authors:  Jun Liang; Wei-Feng Wang; Shao Xie; Xian-Li Zhang; Wei-Feng Qi; Xiu-Ping Zhou; Jin-Xia Hu; Qiong Shi; Ru-Tong Yu
Journal:  Oncol Lett       Date:  2015-04-14       Impact factor: 2.967

6.  CRL Ubiquitin Ligases and DNA Damage Response.

Authors:  Ju-Mei Li; Jianping Jin
Journal:  Front Oncol       Date:  2012-04-09       Impact factor: 6.244

7.  Mutation rate estimation for 15 autosomal STR loci in a large population from Mainland China.

Authors:  Zhuo Zhao; Jie Zhang; Hua Wang; Zhi-Peng Liu; Ming Liu; Yuan Zhang; Li Sun; Hui Zhang
Journal:  Meta Gene       Date:  2015-07-26

8.  The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.

Authors:  Jie Xu; Weihua Zhou; Fei Yang; Guoan Chen; Haomin Li; Yongchao Zhao; Pengyuan Liu; Hua Li; Mingjia Tan; Xiufang Xiong; Yi Sun
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

9.  EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.

Authors:  Qijia Yan; Zhaoyang Zeng; Zhaojian Gong; Wenling Zhang; Xiayu Li; Baoyu He; Yali Song; Qiao Li; Yong Zeng; Qianjin Liao; Pan Chen; Lei Shi; Songqing Fan; Bo Xiang; Jian Ma; Ming Zhou; Xiaoling Li; Jianbo Yang; Wei Xiong; Guiyuan Li
Journal:  Oncotarget       Date:  2015-12-08

10.  BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.

Authors:  Kajal Biswas; Subha Philip; Aditya Yadav; Betty K Martin; Sandra Burkett; Vaibhav Singh; Anav Babbar; Susan Lynn North; Suhwan Chang; Shyam K Sharan
Journal:  Nat Commun       Date:  2018-02-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.